好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Quality Of Life And Disease Progress In Patients With Drug Resistant Epilepsy
Epilepsy/Clinical Neurophysiology (EEG)
P1 - Poster Session 1 (5:30 PM-6:30 PM)
6-012

To compare epilepsy duration and progress and its influence over quality of life in patients in a third level hospital.

Epilepsy is one of the most frequent neurological disorders, it compromises the well-being, quality of life even cognitive and functional changes have been described on individuals who suffer from it. 

It is a cross-sectional and observational study. Our population consists in adults diagnosed with drug resistant epilepsy, individuals with intellectual disability were excluded. QOLIE-31 quality of life survey was applied, this tool consists of 6 subscales and a total score. The results of these scales were grouped in two variables according "age of onset" and "time of evolution".

 

This variables were studied and their mean scores were compared. We analyzed  the results using the software "SPSS VERSION 24". values under "p <0.05"were considered significant.

Sixty patients were enrolled, 60% women (n = 36), with a mean age of 30 ± 24 years. The subjects were classified into 2 groups, those who began their illness in childhood and individuals who began in adolescence or adult stage (after 10 years old), the scores of the scales of quality of life were compared. There were no significant differences in the overall score, however, individuals in early childhood showed lower scores in the domain "cognitive functioning"(p = .047).

When individuals were compared through the time of their illness evolution, we found significantly lower scores on “emotional well-being” subscale(p = .029) in patients with 10 or more years with their epileptic condition and “social function” was affected in subjects with above of 20 years of disease evolution(p = .011).

Early onset epilepsy compromises the cognitive development of our patients while emotional and social well-being are affected as epilepsy evolves, its necessary to give extra attention to theses areas in our patients first approach.

 

Authors/Disclosures
Jaime Olivas
PRESENTER
No disclosure on file
Marco Antonio Diaz Torres, MD (Hospital Universitario) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file